Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece

2017 ◽  
Vol 37 (9) ◽  
pp. 1441-1452 ◽  
Author(s):  
C. Tzanetakos ◽  
A. Tzioufas ◽  
A. Goules ◽  
G. Kourlaba ◽  
T. Theodoratou ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Active Rheumatoid Arthritis ◽  
Certolizumab Pegol ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis

scholarly journals Cost-Utility Analysis of Tocilizumab in Combination with Methotrexate Versus Standard of Care for the Treatment of Rheumatoid Arthritis in Greece

2013 ◽  
Vol 16 (7) ◽  
pp. A565
Author(s):  
K. Athanasakis ◽  
T. Konstantopoulou ◽  
F. Tarantilis ◽  
K. Tsalapati ◽  
E. Vritzali ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Standard Of Care ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis

scholarly journals Cost-Utility Analysis of Tocilizumab Monotherapy Versus Standard of Care for the Treatment of Rheumatoid Arthritis in Greece

2013 ◽  
Vol 16 (7) ◽  
pp. A565
Author(s):  
K. Athanasakis ◽  
T. Konstantopoulou ◽  
F. Tarantilis ◽  
K. Tsalapati ◽  
E. Vritzali ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Standard Of Care ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis ◽  
Tocilizumab Monotherapy
Sign in / Sign up

Export Citation Format

Share Document